Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Glaxo Wellcome/SmithKline Beecham

Executive Summary

Glaxo Chairman Richard Sykes "thinks" the early 1998 break-up of merger talks between the two companies is "the end of the story," but believes that the logic behind the merger is still compelling. "I think there's been enough said about the merger breakdown," Sykes told a July 30 press conference in London. "There really is nothing more to say about it. The logic is still there, the reasons for doing a merger like that are still there, they're still compelling, but that was just an opportunity: it didn't work out, and I think that's the end of the story." Glaxo management is understood to have been working over the summer to try to resurrect the deal
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS032587

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel